131 filings
8-K
CDTX
Cidara Therapeutics Inc
20 May 24
Departure of Directors or Certain Officers
4:04pm
8-K
CDTX
Cidara Therapeutics Inc
15 May 24
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
4:22pm
8-K
CDTX
Cidara Therapeutics Inc
3 May 24
Other Events
8:00am
8-K/A
CDTX
Cidara Therapeutics Inc
29 Apr 24
Entry into a Material Definitive Agreement
4:57pm
8-K
CDTX
Cidara Therapeutics Inc
24 Apr 24
Entry into a Material Definitive Agreement
4:09pm
8-K
tgbj98j2qi5bzl1 u9v
24 Apr 24
Entry into a Material Definitive Agreement
4:07pm
8-K
r7f99by3 w1i83dhv2n
22 Apr 24
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
5:18pm
8-K
vx1x7adw82t0xspd9r
16 Apr 24
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
8:02am
8-K
tjcbegzvbmty5zxx45ve
5 Apr 24
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
f1h2bs6bkudrz
9 Feb 24
Other Events
8:00am
8-K
suna4r7
22 Dec 23
Other Events
7:33am
8-K
o20pzoezh9dg
17 Nov 23
Other Events
1:22pm
8-K
pu2jj e05vqoz2m
16 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
z9hn15
2 Nov 23
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:08pm
8-K
zj7h7muzme47pc17zs7
13 Oct 23
Cidara Therapeutics and Mundipharma receive positive CHMP opinion for rezafungin for the treatment of Invasive Candidiasis in adults1
10:36am
8-K
05sdqka n0d
21 Sep 23
Other Events
1:24pm
8-K
kqbxabolhgo902dfs
6 Sep 23
Cidara Therapeutics Announces Janssen’s Election to Proceed Under its License Agreement Relating to Novel Drug-Fc Conjugates Targeting Influenza
8:05am
8-K
5jr6lta 72hmrsiu
3 Aug 23
Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
4:03pm
8-K
k2mn 3bwemhcd7jkw32
23 Jun 23
Submission of Matters to a Vote of Security Holders
4:07pm
8-K
m3zcwyd5ozoa29u0
11 May 23
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:16pm